5/22/2014 8:22:06 AM
KNOXVILLE, Tenn.--(BUSINESS WIRE)--It has come to the attention of Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (the "Company" or "Provectus"), that an article was published on seekingalpha.com on May 21, 2104, which contains numerous inaccuracies and misstatements about the Company.
Help employers find you! Check out all the jobs and post your resume.
comments powered by